Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-07
2007-08-07
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S349000, C544S253000, C544S355000, C544S238000, C544S295000, C544S357000, C548S453000, C514S256000, C514S414000, C514S314000, C514S338000, C514S252110, C514S307000, C514S252020, C546S168000, C546S276700, C546S146000
Reexamination Certificate
active
11100355
ABSTRACT:
Compounds of Formula I are provided, in which variables are as described herein:Such compounds may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of metabolic, feeding and sexual disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting MCH receptors (e.g., receptor localization studies).
REFERENCES:
patent: 4140775 (1979-02-01), McCall
patent: 4370329 (1983-01-01), Scherm et al.
patent: 4370330 (1983-01-01), Scherm et al.
patent: 4414389 (1983-11-01), Freed
patent: 4616086 (1986-10-01), Witte et al.
patent: 4673675 (1987-06-01), Robba et al.
patent: 4704382 (1987-11-01), Chorvat et al.
patent: 4806536 (1989-02-01), Cross et al.
patent: 4868194 (1989-09-01), Carr et al.
patent: 4921863 (1990-05-01), Sugimoto et al.
patent: 4937246 (1990-06-01), Sugihara et al.
patent: 5179095 (1993-01-01), Oinuma et al.
patent: 5569659 (1996-10-01), Reitz
patent: 5652242 (1997-07-01), Wayne et al.
patent: 5681954 (1997-10-01), Yamamoto et al.
patent: 5688798 (1997-11-01), Godel et al.
patent: 5753659 (1998-05-01), Mills
patent: 5859246 (1999-01-01), Thurkauf et al.
patent: 5869488 (1999-02-01), Shue et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 5965560 (1999-10-01), Glase et al.
patent: 6048876 (2000-04-01), Annoura et al.
patent: 6057371 (2000-05-01), Glennon et al.
patent: 6121267 (2000-09-01), Glase et al.
patent: 6172229 (2001-01-01), Thurkauf et al.
patent: 6200986 (2001-03-01), Bhatnagar et al.
patent: 6251893 (2001-06-01), Maddaford et al.
patent: 6313127 (2001-11-01), Waterson et al.
patent: 6414149 (2002-07-01), Chu-Moyer et al.
patent: 6455528 (2002-09-01), Adachi et al.
patent: 6479495 (2002-11-01), Kosley, Jr. et al.
patent: 6518273 (2003-02-01), Chapman et al.
patent: 6541477 (2003-04-01), Lewicki et al.
patent: 6569861 (2003-05-01), Bakthavatchalam et al.
patent: 6753336 (2004-06-01), Bakthavatchalam et al.
patent: 2001/0039286 (2001-11-01), Dinnell et al.
patent: 2001/0049367 (2001-12-01), Bennani et al.
patent: 2002/0065278 (2002-05-01), Apodaca et al.
patent: 2003/0018034 (2003-01-01), Adachi et al.
patent: 2003/0055064 (2003-03-01), Adachi et al.
patent: 2003/0207882 (2003-11-01), Stocker et al.
patent: 2003/0220324 (2003-11-01), Fotsch et al.
patent: 2004/0229883 (2004-11-01), Bakthavatchalam et al.
patent: 2005/0065162 (2005-03-01), Hutchison et al.
patent: 0390654 (1990-10-01), None
patent: 0624584 (1994-11-01), None
patent: 1378964 (1975-01-01), None
patent: 2002-322163 (2002-11-01), None
patent: 2004-256526 (2004-09-01), None
patent: 9316057 (1993-08-01), None
patent: WO 97/44334 (1997-11-01), None
patent: WO 99/16746 (1999-04-01), None
patent: WO 99/65906 (1999-12-01), None
patent: WO 01/17965 (2001-03-01), None
patent: WO 01-36386 (2001-05-01), None
patent: WO 01/64676 (2001-09-01), None
patent: WO 02/051809 (2002-07-01), None
patent: 02094799 (2002-11-01), None
patent: WO 2004/035556 (2004-04-01), None
patent: WO 2004/037800 (2004-05-01), None
patent: 2005110989 (2005-11-01), None
patent: 2005110989 (2007-01-01), None
J.R. Boissier et al., “Synthesis and Pharmacological Study of New Piperazine Derivatives”, Sep. 1963, pp. 551-554.
Tokushi Hanano et al.; “Novel DMARDs on the Basis of a New Concept of Dual Cytokine Regulation, TNF-× Suppression and IL-10 Augmentation”, Bioorganic & Medicinal Chemistry Letters 10 (2000) pp. 881-884.
Dina Manetti et al., “Hybridized and Isosteric Analogues of N1-Acetyl-N4—dimethyl-piperazinium Iodide (ADMP) and N1-Phenyl-N4—dimethyl-piperazinium Iodide (DMPP) with Central Nicotinic Action”, Bioorganic & Medicinal Chemistry 7 (1999) pp. 457-465.
International Search Report for co-owned Application No. PCT/US2005/011890, mailed Jul. 11, 2005.
Premilla N. Arasasingham, et al., “Structure-Activity Relationship of (1-Aryl-2-piperazinylethyl) piperazines: Antagonists for the AGRP/Melanocortin Receptor Binding”, J. Med. Chem. (2003) 46: 9-11.
Kje-Kee Kim et al., “Synthesis and Biological Evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new Class of Histone Deacetylase Inhibitors”, J. Med. Chem. (2003) 46: 5745-5751.
Marc Nazare et al., “Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand”, Bioorganic & Medicinal Chemistry Letters (2004) 14: 2801-2805.
Ning Xi et al., “Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core”, Bioorganic & Medicinal Chemistry Letters (2004) 14: 377-381.
International Search Report for International Application No.: PCT/US2005/011896, Mailed Dec. 12, 2005.
Carpenter, A. J. and D. L. Hertzog “Melanin-Concentrating Hormone Receptor Antagonists as Potential Antiobesity Agents,” Expert Opin. Ther. Patents (2002) 12(11): 1639-1646.
Gilbert, A. M. et al “Modulation of Selective Serotonin Reuptake Inhibitor and 5-HTIA Antagonist Activity in 8-aza-bicyclo[3.2.1]octane Derivatives of 2,3-dihydro-1,4-benzodioxane,” Bioorganic and Medicinal Chemistry Letters (2004) 14: 515-518.
Saleh, M. A. et al. “The Synthesis of 2,7-Substituted Octahydro-2H-Pyrido[1,2-a] Pyrazines, Analogues of Quinolizidine and Piperazine Drugs,” Tetrahedron (1994) 50(6): 1811-1820.
Written Opinion of the International Searching Authority for International Application No. PCT/US2005/021340. Mailed Oct. 31, 2006.
Written Opinion of the International Searching Authority for International Application No. PCT/2005/011890. Mailed Jul. 11, 2005.
Chenard Bertrand L.
Doller Dario
Ghosh Manuka
Gustavson Linda M.
Hutchison Alan J.
Berch Mark L.
Cantor & Colburn LLP
Moore Susanna
Neurogen Corporation
LandOfFree
Substituted 1-benzyl-4-substituted piperazine analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1-benzyl-4-substituted piperazine analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1-benzyl-4-substituted piperazine analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3874246